Lymphatic Phenotype in Noonan Syndrome Spectrum Disorders

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 27, 2024

Primary Completion Date

April 1, 2025

Study Completion Date

April 1, 2025

Conditions
Lymphatic System Disorders CongenitalLymphatic DiseasesNoonan SyndromeLymphatic Disease
Interventions
DIAGNOSTIC_TEST

Dynamic contrast-enhanced lymphangiography

The subject is placed supine on a detachable MR imaging table, outside the scanning room. Both inguinal regions are prepared under sterile conditions. Using Ultrasound guidance, the thoracic duct outlet at the left venous angle is identified. Under US guidance, a small 25 gauge needle is placed at the corticomedullar junction of an inguinal lymph node on each side. The needle position is confirmed and checked that there is no extravasation at saline injection under US visualization. The subject is then transferred to the MR imaging machine. First, pre-contrast imaging is performed, this takes around 20 minutes.

Trial Locations (1)

6500 HB

Radboudumc, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT06267807 - Lymphatic Phenotype in Noonan Syndrome Spectrum Disorders | Biotech Hunter | Biotech Hunter